Mitralign, Inc. Announces Closing of $24M Series C Financing  
12/3/2007 12:53:47 PM

TEWKSBURY, Mass.--(BUSINESS WIRE)--Mitralign Inc. today announced the closing of a $24M Series C financing. This financing will enable the Company to complete its initial clinical experience and obtain CE Mark approval of the Mitralign System. This round, co-led by Medtronic [NYSE: MDT] and Johnson and Johnson Development Corporation, also includes Oakwood Medical, Palisades Capital and Accelerated Technology Partners. Existing investors Forbion, Giza, Oxford Biosciences and Triathlon Medical Venture Partners also participated in the round.